Artificial Blood Experiment: Is Your City Participating?
July 7, 2006 — -- Northfield Lab's experimental blood substitute Polyheme is currently in randomized phase III clinical trials recruiting patients without informed consent all over the country. At one point, it was being tested in as many as 27 cities; it is still being tested in 23 hospitals in 20 cities.
With the FDA's approval, Northfield Lab has recruited hospitals to participate in the trial study with exemption from informed consent requirements on study participants. Although Northfield Lab claims that extensive information on the study has been made public, a vast majority of the general public has never heard of the trial.
Below is a list of the cities and hospitals that are currently participating in the Polyheme trials. Check the list to see if you live an area where you could become a trial participant without your informed consent.
To opt out of the study, contact Northfield Labs (http://www.northfieldlabs.com/contact.html) or a participating hospital and request a blue bracelet. If worn, you will be exempt from the trial.
UC San Diego Medical Center, San Diego, Calif.; No longer recruiting
Scripps Mercy, San Diego, Calif.; No longer recruiting
Denver Health Medical Center, Denver, Colo.
Christiana Hospital, Newark, Del.
Medical Center of Central Georgia, Macon, Ga.
Loyola University Medical Center, Maywood, Ill.
Wishard Memorial Hospital, Indianapolis, Ind.
Methodist Hospital of Indiana, Indianapolis, Ind.
University of Kansas Medical Center, Kansas City, Kan.
University of Kentucky Medical Center, Lexington, Ky.
Detroit Receiving Hospital, Detroit, Mich.
Sinai Grace Hospital, Detroit, Mich.
The Mayo Clinic, Rochester, Minn.
Albany Medical Center, Albany, N.Y.; Suspended
Duke University Medical Center, Durham, N.C.
MetroHealth Medical Center, Cleveland, Ohio; Suspended
University of Cincinnati Medical Center, Cincinnati, Ohio
Miami Valley Hospital, Dayton, Ohio